The 14th consecutive presence of Pars Isotope at the Annual European Association of Nuclear Medicine Congress (EANM 2025)

Pars Isotope, as the sole producer and supplier of diagnostic and therapeutic radiopharmaceuticals in Iran, participated prominently and impressively in the 39th European Association of Nuclear Medicine Congress (EANM 2025).

Pars Isotope, a corporate member of the European Association of Nuclear Medicine, participated for the fourteenth consecutive time in this scientific and specialized event to promote its scientific, technical, and industrial capabilities internationally.

At this year’s congress, Pars Isotope occupied a 100-square-meter booth in the main exhibition area, showcasing its achievements, new products, and extensive capabilities in producing radiopharmaceuticals for nuclear medicine centers.

During the three-day exhibition, over 100 specialists, managers, and companies active in nuclear medicine visited the Pars Isotope booth, while more than 30 specialized and managerial meetings were held to develop scientific and commercial collaborations.

The PARS-GalluGen generator, Rhenium-SCT, and PARS-TECTO PSMA kit were highlights among the presented products, drawing considerable attention from visitors and specialists. These advanced radiopharmaceuticals, produced by Pars Isotope, showcase Iran’s significant scientific and technical capabilities in the global nuclear medicine field.

Through its distinguished participation at the EANM 2025 Congress, Pars Isotope once again demonstrated Iran’s production capacity and specialized expertise in advanced radiopharmaceuticals to the global nuclear medicine community